Barclays’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.6M | Buy |
|
|||||
|
2025
Q1 | $3.63M | Buy |
|
|||||
|
2024
Q4 | $2.83M | Sell |
|
|||||
|
2024
Q3 | $4.45M | Buy |
|
|||||
|
2024
Q2 | $2.55M | Buy |
|
|||||
|
2024
Q1 | $3.29M | Buy |
|
|||||
|
2023
Q4 | $491K | Buy |
|
|||||
|
2023
Q3 | $81K | Buy |
|
|||||
|
2023
Q2 | $109K | Sell |
|
|||||
|
2023
Q1 | $1.47M | Sell |
|
|||||
|
2022
Q4 | $896K | Buy |
|
|||||
|
2022
Q3 | $14K | Sell |
|
|||||
|
2022
Q2 | $66K | Sell |
|
|||||
|
2022
Q1 | $161K | Sell |
|
|||||
|
2021
Q4 | $873K | Buy |
|
|||||
|
2021
Q3 | $757K | Buy |
|
|||||
|
2021
Q2 | $231K | Sell |
|
|||||
|
2021
Q1 | $1.08M | Buy |
|
|||||
|
2020
Q4 | $464K | Sell |
|
|||||
|
2020
Q3 | $231K | Buy |
|
|||||
|
2020
Q2 | $246K | Buy |
|
|||||
|
2020
Q1 | $70K | Sell |
|
|||||
|
2019
Q4 | $168K | Sell |
|
|||||
|
2019
Q3 | $171K | Sell |
|
|||||
|
2019
Q2 | $290K | Buy |
|
|||||
|
2019
Q1 | $91K | Buy |
|
|||||
|
2018
Q4 | $88K | Sell |
|
|||||
|
2018
Q3 | $325K | Buy |
|
|||||
|
2018
Q2 | $162K | Sell |
|
|||||
|
2018
Q1 | $184K | Buy |
|
|||||
|
2017
Q4 | $18K | Sell |
|
|||||
|
2017
Q3 | $52K | Buy |
|
|||||
|
2017
Q2 | $7K | Sell |
|
|||||
|
2017
Q1 | $308K | Buy |
|
|||||
|
2016
Q4 | $27K | Buy |
|
|||||
|
2016
Q3 | $2K | Sell |
|
|||||
|
2016
Q2 | $20K | Buy |
|
|||||
|
2016
Q1 | $18K | Sell |
|
|||||
|
2015
Q4 | $47K | Sell |
|
|||||
|
2015
Q3 | $85K | Buy |
|
|||||
|
2015
Q2 | $99K | Buy |
|
|||||
|
2015
Q1 | $7K | Sell |
|
|||||
|
2014
Q4 | $61K | Buy |
|